Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Schick Technologies plans mid-year 510(k) submission for Spot Sensor mammography device.

This article was originally published in The Gray Sheet

Executive Summary

SCHICK TECHNOLOGIES PLANS SPOT SENSOR 510(k) SUBMISSION BY MID- 1998 the Long Island City, New York firm says. The low-cost mammography sensors "are designed to fit existing stereotactic needle biopsy systems and provide instant high-definition radiographs," Investor Relations Director Eli Schick told a Jan. 26 session of Rodman and Renshaw's musculoskeletal conference in Boston.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT009522

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel